Form 6-K Fresenius Medical Care For: Feb 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
UPDATE: Fresenius Medical Care (FMS) Misses Q4 EPS Expectations
February 24, 2016 8:08 AM EST(Updated - February 24, 2016 9:46 AM EST)
Fresenius Medical Care (NYSE: FMS) reported Q4 EPS of $0.52, versus the analyst estimate of $0.58. Revenue for the quarter came in at $4.35 million versus the consensus estimate of $4.41 million.
Adjusted EPS was reported as $1.04 prior, which didn't... More
